D
Sell
12/14/2020Upgraded
DNA Brands, Inc. (DNAXD) was upgraded to D- from E+ on 12/14/2020 due to an increase in the volatility index and total return index.
E
Sell
11/2/2020Downgrade
DNA Brands, Inc. (DNAX) was downgraded to E+ from D- on 11/2/2020 due to a decline in the volatility index.
D
Sell
10/16/2020Upgraded
DNA Brands, Inc. (DNAX) was upgraded to D- from E+ on 10/16/2020 due to an increase in the volatility index and total return index.
E
Sell
9/30/2020Downgrade
DNA Brands, Inc. (DNAX) was downgraded to E+ from D- on 9/30/2020 due to a decline in the volatility index.
D
Sell
9/11/2020Upgraded
DNA Brands, Inc. (DNAX) was upgraded to D- from E+ on 9/11/2020 due to a noticeable increase in the volatility index and total return index.
E
Sell
5/1/2020Downgrade
DNA Brands, Inc. (DNAX) was downgraded to E+ from D on 5/1/2020 due to a significant decline in the efficiency index, solvency index and growth index. Net income declined 788.99% from -$21.8 to -$193.8, earnings per share declined from -$0.0002 to -$0.0013, and operating cash flow declined 295.5% from $31.1 to -$60.8.
D
Sell
11/25/2019Downgrade
DNA Brands, Inc. (DNAX) was downgraded to D from C on 11/25/2019 due to a substantial decline in the volatility index, total return index and efficiency index. Total capital declined 0.45% from -$535.4 to -$537.8.
C
Hold
6/20/2014Downgrade
DNA Brands, Inc. (DNAX) was downgraded to C from C+ on 6/20/2014 due to a substantial decline in the valuation index and total return index.
C
Hold
6/2/2014Upgraded
DNA Brands, Inc. (DNAX) was upgraded to C+ from C on 6/2/2014 due to a significant increase in the valuation index, total return index and solvency index. The quick ratio increased from 0.02 to 0.04, and debt to equity declined from -0.44 to -0.34.
